British EBF role in global Strangles research recognised
Wed 10 Mar 2021
Funding provided by the British EBF has been recognised as findings of a DNA investigation highlighting the ‘unbridled globetrotting’ of the Strangles pathogen in horses is published.
In the largest ever study of its kind into an equine pathogen, which was published today in the journal ‘Microbial Genomics’, scientists in 18 countries used the latest DNA sequencing techniques to track the bacteria Streptococcus equi as it caused the disease strangles in horses around the world.
Strangles, caused by Streptococcus equi, is the most frequently diagnosed infectious disease of horses, with 600 outbreaks estimated to occur in the United Kingdom each year. Streptococcus equi invades the lymph nodes of head and neck, causing them to swell and form abscesses that can literally strangle, in around 2% of cases, the horse to death. Some of the horses that recover from strangles remain persistently infected. These apparently healthy animals shed bacteria into the environment and spread the disease to other horses with which they come into contact.
“Using standard diagnostic testing, the Streptococcus equi strains look almost identical, however by carefully examining the DNA of the bacteria, we have been able to track different variants as they spread across the world” said Prof. Matthew Holden of the University of St Andrews.
“Piecing the puzzle together, we showed that cases in Argentina, the United Kingdom and the United Arab Emirates were closely linked. Along with other examples, we provide evidence that the global trade and movement of horses is helping to spread the disease.”
“Building on top of the data generated, we provide an online surveillance platform for strangles enabling labs to upload and interpret their genomic and epidemiological data in close to real-time. Pathogenwatch will be used to monitor the emergence and spread of new lineages to help inform interventions and policy making decisions” said Prof David Aanensen of The Centre for Genomic Pathogen Surveillance, University of Oxford.
“Strangles was first described in medieval times and, with the exception of Iceland, affects horses in all corners of the world. Freedom from this disease enjoyed by Iceland is by virtue of a ban on the import of horses, which has been in place for over 1,000 years” commented Prof. James Gilkerson of the University of Melbourne and Chair of the International Equine Infectious Diseases Committee. “This new study provides evidence of the important role played by the movement of horses in spreading this disease, providing new opportunities for interventions that prevent future outbreaks.”
“This has been an incredible team effort, which was only possible through the collaboration of leading researchers from twenty-nine different scientific institutes in eighteen countries” said Dr. Andrew Waller of Intervacc AB.
“Horses are transported all over the world as they move to new premises or attend competitions and events. New cases of strangles can be prevented by treating carriers before they pass on the bacteria. This new research in the field of strangles and the new online Pathogenwatch resource provide an opportunity to track the course of infections, reigning-in Streptococcus equi’s globetrotting lifestyle by shutting the stable door before this horse pathogen has bolted!”
Simon Sweeting, Chairman of the British EBF, commented:
“Equine veterinary research is an integral part of the British European Breeders’ Fund’s support for the horse racing and breeding industry. The Trustees are delighted to have been able to provide financial resources to Dr Waller and his international colleagues, which has enabled this vital work on tracking and managing the Strangles pathogen in the horse population.”
To date, the British EBF has directly funded over £1,250,000 of equine veterinary research projects, in addition to our prize money allocations.
Since 2000, they have wholly or partly funded veterinary research covering subjects as diverse as the Equine Genome Project and the identification of virulence factors associated with Rhodococcus. In recent years, the focus has been on research specifically relating to the breeding industry and has covered areas such as the effects of light and temperature on delayed ovulation and an extensive study in to potential alternatives to traditional parasite control in thoroughbred mares and young-stock.
Read or download the full published paper here: https://doi.org/10.1099/mgen.0.000528
About Intervacc: Intervacc AB is a Swedish company within animal health developing safe, effective vaccines for animals. The Company’s vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company´s research and development work